Bushu Pharma is a leading pure play Contract Development and Manufacturing Organization in Japan
Location: Japan, Saitama
Employees: 1001-5000
Founded date: 1981
Investors 1
| Date | Name | Website |
| 28.05.2023 | Kohlberg K... | kkr.com |
Mentions in press and media 3
| Date | Title | Description |
| 11.09.2024 | Pharmaceutical CDMO Market Size to Achieve USD 345.6 Billion by 2033 | The global pharmaceutical CDMO market size is calculated at USD 184.9 billion in 2024 and is expected to achieve around USD 345.6 billion by 2033, representing a healthy CAGR of 7.2% from 2024 to 2033. Ottawa, Sept. 11, 2024 (GLOBE NEWSWIRE... |
| 27.07.2022 | Bushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific and Offering Customer Value with Its Advanced Gateway to Asia Services | The Gateway to Asia initiative ensures quality and timely delivery through shorter lead times, temperature and humidity control, and streamlined urgent order processing SAN ANTONIO, July 27, 2022 /PRNewswire/ -- Based on its recent analysis... |
| 24.11.2021 | Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region | KAWAGOE, Japan, Nov. 24, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to Asia" service to four countries ac... |